Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2020-03-20 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东部分股权解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the partial release of pledged shares by a shareholder holding more than 5% of the company's shares. It details the number of shares released from pledge, the shareholder's total holdings, and the remaining pledged shares. There is no financial report, earnings data, or management discussion. The content focuses on share pledge status and shareholder information. This fits the category of a Major Shareholding Notification, as it involves disclosure about significant share ownership and pledge changes by a major shareholder.
2020-03-20 Chinese
关于使用闲置募集资金进行现金管理到期赎回并继续进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the use of idle raised funds for cash management through purchasing low-risk structured deposit products. It includes specifics about the financial product, investment amounts, risk control, and compliance with regulatory approvals. The document is not a full financial report but rather a regulatory announcement about financing activities related to the use of raised funds. It does not contain comprehensive financial statements or management discussion typical of annual or interim reports. It also does not fit categories like earnings release, board changes, or legal proceedings. The content aligns with updates on company fundraising and capital structure usage, which corresponds to the Capital/Financing Update (CAP) category.
2020-03-17 Chinese
关于召开2020年第一次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2020 first extraordinary general meeting of shareholders for the company 中源协和细胞基因工程股份有限公司. It includes information about the meeting date, voting methods (including online voting), agenda items to be discussed, voting procedures, attendance requirements, and an authorization letter for proxy voting. There is no financial data, earnings, or report content included. The document serves as a notice or announcement to shareholders about the meeting and how to participate, rather than the results of the meeting or the report itself. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-03-17 Chinese
关于龚虹嘉先生收到《中国证监会结案告知书》及《浙江监管局行政监管措施决定书》的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding a regulatory action involving an individual (龚虹嘉) receiving a closure notice and an administrative regulatory decision from the China Securities Regulatory Commission (CSRC). It details the regulatory measures taken against the individual for failure to disclose financing arrangements properly. The document is short (717 characters) and does not contain financial statements or detailed financial data. It is an announcement of a regulatory matter rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance-related disclosures that do not fit other specific categories.
2020-03-15 Chinese
关于持股5%以上股东部分股权解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company regarding the partial release of pledged shares by a shareholder holding more than 5% of the company's stock. It details the number of shares released from pledge, the remaining pledged shares, and the shareholder's total holdings. The document is short (1234 characters) and focuses on share pledge status updates rather than financial results, management changes, or regulatory filings. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or related shareholding status changes such as pledges.
2020-03-13 Chinese
2020年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2020 First Extraordinary General Meeting" of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It contains detailed meeting agenda, voting procedures, and a specific investment proposal to be voted on by shareholders. The content includes meeting logistics, shareholder rights, and detailed descriptions of the investment proposal, but it is clearly a set of meeting materials rather than a report or announcement of results. The document is about the shareholders' meeting agenda and materials, which fits the definition of AGM Information (AGM-R). The document length is 9039 characters, which is substantial and contains detailed meeting materials, not just a brief announcement or voting results. Therefore, the classification is AGM Information (AGM-R) with high confidence.
2020-03-13 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.